PALI
Palisade BioBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PALI vs peer average
66/100
PALI vs. peer average (B vs. C)
Grade spread
A 3 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALLO is the first available peer comparator.
Another small-cap development-stage biotech where valuation is driven more by pipeline milestones and cash runway than current revenues, though modality and indication differ.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PALI
Palisade Bio
ALLO
Allogene Therapeutics
Grade
B
A
Momentum
85
96
Value
41
41
Sentiment
55
58
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ALLO
PALI / ALLO
Grade Position
In line
PALI vs. peer average (B vs. C)
66/100
Momentum
85
ALLOValue
41
PALISentiment
55
ALLORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PALI
ALLO is the first peer returned for this comparison set.